Product Images Bupropion Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Bupropion Hydrochloride NDC 59651-848 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 100 mg (100 Tablets Bottle) - buprop fig1
This text provides information about extended-release tablets containing Bupropion hydrochloride 100 mg, marketed as Zyban®. The tablets are distributed by Aurobindo Pharma USA, Inc. and should be dispensed in a tight, light-resistant container. The warning advises against combining this medication with other forms of bupropion hydrochloride. The storage temperature is specified, and pharmacists are instructed to dispense the medication with an accompanying patient guide. Instructions to protect the tablets from light and moisture are also included. The usual adult dosage and information on accessing medication guides are provided as well.*
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 150 mg (100 Tablets Bottle) - buprop fig2
Each extended-release tablet contains Bupropion hydrochloride 150 mg. It is dispensed in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by Aurobindo Pharma USA, Inc. The tablets should be stored at room temperature, protected from light and moisture. It is important not to use this medication in combination with ZYBAN or other medicines containing bupropion hydrochloride. The usual adult dosage information is available in the prescribing guide included with the medication. Additional details for pharmacists, such as how to dispense the medication and where to print medication guides, can be found at the website provided.*
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 200 mg (100 Tablets Bottle) - buprop fig3
This is a medication description for an extended-release tablet containing Bupropion Hydrochloride, USP 200 mg. It is manufactured by GlaxoSmithKline and distributed by Aurobindo Pharma USA, Inc. The medication should be stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F) and out of reach of children. It is important not to combine this medication with any other medicines containing bupropion hydrochloride and to follow the guidance provided by the prescribing information. Additional details about dosage and administration should be obtained from the accompanying prescribing information or Medication Guides, available at the provided website.*
str - buprop str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
